Marc Willuhn, PhD
Dr. Marc Willuhn has more than 20 years’ experience in the pharmaceutical and biotech industry. Previously, Dr. Willuhn was VP R&D at Fresenius Kabi and Head of the Innovation & Development Centre in Uppsala, Sweden, and Director of Process Development at Baxter Healthcare in Brussels, Belgium. During this time, he was involved in the registration of several new i.v. lipid emulsions in the US. Dr. Willuhn studied chemistry at Gerhard Mercator University in Germany and at McMaster University in Canada. He obtained his Ph.D. in organic chemistry at the Max Planck Institute for Coal Research in Germany and carried out post-doctoral research at the University Rene Descartes in Paris, France.